| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.25 | 9e-07 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.25 | 1e-06 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.24 | 1e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.24 | 2e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-06 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.23 | 4e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.23 | 8e-06 |